里格尔制药

US · RIGL #3318 按市值排名

45.97 -1.28 -2.71%

实时 - 追踪5344个代码 - 心跳于200秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了4家。
机构持股总比例下降了2.3个百分点。

机构持股

机构持股比例: 90.89% -2.31pp
机构数量: 201 -4
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund55.27%

Hedge Fund30.00%

Public Company3.03%

Individual/Insider1.74%

Government Pension Fund0.73%

Bank/Investment Bank0.62%

Family Office/Trust0.56%

Private Company0.36%

Insurance Company0.25%

Other7.44%

主要股东截至 2026-06-30

BlackRock 10.38% · 1.94M 股

Soleus Capital Management, L.P. 9.87% · 1.84M 股

Armistice Capital LLC 8.95% · 1.67M 股

State Street Global Advisors 5.57% · 1.04M 股

Vanguard Capital Management, LLC 4.85% · 906.84K 股

American Century Investment Management 3.97% · 741.72K 股

LSV Asset Management 3.86% · 721.67K 股

Acadian Asset Management LLC 3.17% · 591.69K 股

D. E. Shaw & Co., L.P. 2.90% · 542.54K 股

Geode Capital Management, LLC 2.59% · 483.18K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 26次买入 · 22次卖出

姓名	职务	持股比例
Raul Rodriguez	Chief Executive Officer	0.96%
Dean Schorno	Chief Financial Officer	0.24%
David Santos	Executive Vice President	0.12%
Raymond Furey	General Counsel	0.08%
Walter Moos	Independent Director	0.07%
Jane Wasman	Independent Director	0.07%
Gregory Lapointe	Independent Chairperson	0.07%
Alison Hannah	Independent Director	0.06%
Kamil Jackson	Independent Director	0.05%
Lisa Rojkjaer	Chief Medical Officer	0.02%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-01	Dean Schorno	Chief Financial Officer	Derivative Exercise and Retained	+4,600	$12.70–24.20
2026-08-31	Raul Rodriguez	Chief Executive Officer	Sale to Issuer	-2,424	$47.50
2026-08-31	Dean Schorno	Chief Financial Officer	Sale to Issuer	-928	$47.50
2026-08-31	Raymond Furey	General Counsel	Sale to Issuer	-877	$47.50
2026-08-31	David Santos	Executive Vice President	Sale to Issuer	-874	$47.50
2026-07-07	Alison Hannah	Independent Director	Other Acquisition	+24,400	--
2026-06-21	Kamil Jackson	Independent Director	Automatic Disposition	-2,500	$35.00
2026-06-16	Raul Rodriguez	Chief Executive Officer	Other Derivative Acquisition	+31,700	$22.49
2026-06-16	Lisa Rojkjaer	Chief Medical Officer	Other Derivative Acquisition	+16,769	$14.90–22.49
2026-06-16	Dean Schorno	Chief Financial Officer	Other Derivative Acquisition	+7,394	$22.49
2026-06-16	Raymond Furey	General Counsel	Other Derivative Acquisition	+7,394	$22.49
2026-06-16	David Santos	Executive Vice President	Other Derivative Acquisition	+7,394	$22.49
2026-05-31	Raul Rodriguez	Chief Executive Officer	Sale to Issuer	-2,424	$29.86
2026-05-31	Lisa Rojkjaer	Chief Medical Officer	Sale to Issuer	-850	$29.86
2026-05-31	Dean Schorno	Chief Financial Officer	Derivative Exercise and Sale	-928	$12.70–29.86
2026-05-31	Dean Schorno	Chief Financial Officer	Derivative Exercise and Retained	+2,453	$12.70–18.70
2026-05-31	Raymond Furey	General Counsel	Sale to Issuer	-877	$29.86
2026-05-31	David Santos	Executive Vice President	Sale to Issuer	-874	$29.86
2026-05-25	Kamil Jackson	Independent Director	Automatic Disposition	-2,500	$29.17
2026-05-14	Walter Moos	Independent Director	Other Acquisition	+5,750	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。